Rallis India is currently trading at Rs. 226.35, up by 7.30 points or 3.33% from its previous closing of Rs. 219.05 on the BSE.
The scrip opened at Rs. 219.00 and has touched a high and low of Rs. 227.80 and Rs. 218.25 respectively. So far 110472 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 232.35 on 25-Jun-2014 and a 52 week low of Rs. 130.40 on 07-Aug-2013.
Last one week high and low of the scrip stood at Rs. 227.80 and Rs. 209.10 respectively. The current market cap of the company is Rs. 4380.41 crore.
The promoters holding in the company stood at 50.09% while Institutions and Non-Institutions held 21.64% and 28.26% respectively.
Crop protection products-maker Rallis India has introduced a new insecticide for the control of sucking pests in paddy. This is the third new product to be launched this fiscal by the Tata group company. The product, named Hunk, also has phytotonic qualities that enhance overall crop health, besides combating pests.
Moreover, the company has three more products in the pipeline for this year. Of these, two would be in the insecticide segment and the third in the fungicide space. The new products will be a mix of technologies sourced from overseas and those developed in-house.
The company is quickening the pace of its new launches as El Nino fears recede and the monsoons appear to be back on track, paving the way for a pick-up in farm activities and resulting in increased sales of crop protection products.
The company’s net profit for the quarter jumped over two fold at Rs 13.08 crore as compared to Rs 5.99 crore for the quarter ended June 30, 2013. Its total income from operations increased by 8.11% to Rs 292.12 crore for the quarter under review from Rs 270.19 crore for the corresponding quarter of the previous year.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: